Ozempic® (Semaglutide) Injection Pen
For Type 2 Diabetes Management & Weight Control
General Information
-
Brand Name: Ozempic®
-
Active Ingredient: Semaglutide
-
Concentration: 2 mg/3 mL (0.68 mg/mL)
-
Dosage Form: Prefilled injection pen
-
Manufacturer: Novo Nordisk
-
Country of Origin: Denmark 🇩🇰
-
Packaging: Each box contains 1 prefilled pen and needles (NovoFine®)
-
Administration: Subcutaneous injection
Description
Ozempic® is a GLP-1 receptor agonist designed to help adults with Type 2 Diabetes Mellitus improve blood sugar control, alongside diet and exercise. It also provides weight management benefits by reducing appetite and slowing digestion.
With once-weekly administration, Ozempic® offers a convenient treatment option for long-term glucose regulation and cardiovascular risk reduction.
Key Features
-
Once-weekly injection for convenience.
-
Helps lower HbA1c levels and maintain blood sugar stability.
-
Supports weight loss in patients with diabetes and obesity.
-
Reduces risk of major cardiovascular events (heart attack, stroke, death).
-
Available in multi-dose pens with adjustable increments (0.25 mg or 0.5 mg).
Indications
Ozempic® is indicated for:
-
Adults with Type 2 Diabetes Mellitus to improve glycemic control.
-
Reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
-
May also support weight management in certain patients under physician guidance.
Benefits
-
Effective blood sugar reduction
-
Clinically proven weight management support
-
Low risk of hypoglycemia compared to some other treatments
-
Cardiovascular protection for high-risk patients
-
Easy-to-use, prefilled pen system
Dosage & Administration
-
Starting dose: 0.25 mg once weekly for 4 weeks (for tolerance).
-
Maintenance dose: 0.5 mg once weekly.
-
Dose may be increased to 1 mg or 2 mg once weekly, depending on patient needs and physician recommendation.
-
Administer subcutaneously in the abdomen, thigh, or upper arm.
Precautions
-
Prescription only medication.
-
Not for patients with Type 1 Diabetes or diabetic ketoacidosis.
-
Not recommended for pregnant or breastfeeding women.
-
Common side effects: nausea, vomiting, diarrhea, constipation.
-
Rare but serious risks: thyroid tumors, pancreatitis.
✨ Ozempic® – Made in Denmark, trusted worldwide for diabetes control and cardiovascular protection. ✨
